25th North American ISSX Meeting

We are delighted to extend a warm invitation to you for the 25th North American Meeting of the International Society for the Study of Xenobiotics (ISSX), taking place at The Westin Boston Seaport District in Boston, Massachusetts, from September 10th to 13th, 2023.

This prestigious event, organized by the Meeting Organizing Committee, offers a unique platform for researchers from both academia and industry to come together, fostering collaboration, networking, and the exchange of groundbreaking ideas. The 25th North American ISSX Meeting promises to be an engaging and enlightening experience for all attendees.

The scientific program for this meeting is exceptionally curated, featuring a diverse range of topics in the study of xenobiotics. Renowned experts from around the world will present their latest findings, innovations, and research breakthroughs in various areas such as drug metabolism, toxicology, pharmacokinetics, and drug-drug interactions. This stimulating program guarantees valuable insights and opportunities for attendees to expand their knowledge and stay at the forefront of this rapidly evolving field.

Alongside the exceptional scientific content, the meeting offers access to state-of-the-art exhibits, where attendees can explore the latest technologies, services, and products in the field of xenobiotic research. This provides a remarkable chance to interact with industry leaders, engage in fruitful discussions, and discover cutting-edge advancements that can enhance your research endeavors.

Similar Events

You May Like


International Society for the Study of Xenobiotics


ISSX is the premier scientific organization for researchers interested in the metabolism and disposition of xenobiotics. With a strong international base of members from more than 50 countries, ISSX works to advance research and education on the interplay of living systems with medicines and chemicals for the benefit of society worldwide. Including members from both academia and industry, ISSX provides a home for likeminded research scientists and future scientists in toxicology, pharmacology, molecular biology, and other disciplines related to the study of xenobiotics.

10 - 13 Sep 2023

Greg LoewenPosted 7 months ago

Senior Director Business Development

SOLVO Biotechnology | A Charles River Company

Review Title

Overall, this was a good event, although the vendor hall could have been better.

Speakers and Delegates
Industry Experts and Thought Leaders

Associate Professor
Senior Director Drug Metabolism and Pharmacokinetics
Director DMPK

Sponsors and Exhibitors
Brand, Media and Promotional Partners


SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face.


BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services.


Pharmaron (Stock Code: 300759.SZ/3759.HK) is a premier R&D service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufactur

Eurofins Discovery

Eurofins Discovery has supported Drug Discovery research for >40 years. Our partners inspire us to innovate in the pursuit of life-changing cures. We provide our experience, depth, and breadth in the form of innovative testing services and product to

SOLVO Biotechnology | A Charles River Company

With 20 years of experience and 500 customers in 40 countries, SOLVO Biotechnology is the leading provider of transporter services and products. Leveraging our expertise in efflux and uptake transporters, SOLVO generates quality reports for submissio

Frontage Laboratories, Inc

Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals.


Get emails from us

Thank you
Oops! Something went wrong